OR WAIT null SECS
March 02, 2016
Data integrity has become a more serious compliance problem at pharmaceutical manufacturing plants throughout the world.
January 21, 2016
FDA issued a warning letter to Chan Yat Hing Medicine Factory for CGMP violations.
January 14, 2016
FDA issued a warning letter to Zhejiang Hisun Pharmaceutical Co., Ltd., as a result of inspections that took place on March 2–7, 2015 at the Taizhou City, Zhejiang Province, API manufacturing facility.
January 07, 2016
The Office of Prescription Drug Promotion issues all-time low number of violation letters in 2015.
January 06, 2016
FDA issues a Warning Letter to Cadila Healthcare Limited for cGMP violations.
December 30, 2015
Inadequate response to violations cited in a 2014 inspection leads to an FDA warning letter for Sun Pharmaceutical Industries.
November 04, 2015
FDA noted multiple manufacturing, testing, and labeling violations at American Family Pharmacy’s Indianapolis facility.
November 02, 2015
New program emphasizes quality, risk, and global collaboration.
October 16, 2015
FDA issued a warning letter to API manufacturer Unimark Remedies Ltd. for cGMP violations at its facility in India.
September 16, 2015
FDA issues warning letter to Jaychem Industries, Auckland, New Zealand for violating CGMP regulations.